Your browser doesn't support javascript.
loading
Estimating New Eligibility and Maximum Costs of Expanded Medicare Coverage of Semaglutide for Cardiovascular Risk Prevention.
Chaitoff, Alexander; Bendicksen, Liam; Feldman, William B; Zheutlin, Alexander R; Lalani, Hussain S.
Afiliação
  • Chaitoff A; Center for Healthcare Delivery Sciences, Division of Pharmacoepidemiology, Department of Medicine, Brigham and Women's Hospital, Boston; and Harvard Medical School, Boston, Massachusetts.
  • Bendicksen L; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Feldman WB; Harvard Medical School, Boston; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston; and Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women
  • Zheutlin AR; Division of Cardiology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
  • Lalani HS; Harvard Medical School, Boston; and Division of General Internal Medicine and Primary Care, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Ann Intern Med ; 177(10): 1440-1442, 2024 Oct.
Article em En | MEDLINE | ID: mdl-39186788
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Peptídeos Semelhantes ao Glucagon Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Peptídeos Semelhantes ao Glucagon Idioma: En Ano de publicação: 2024 Tipo de documento: Article